Provided by Tiger Trade Technology Pte. Ltd.

ResMed

221.10
-1.7300-0.78%
Pre-market: 218.55-2.5500-1.15%04:06 EDT
Volume:1.31M
Turnover:290.07M
Market Cap:31.89B
PE:21.20
High:224.04
Open:222.63
Low:220.00
Close:222.83
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.36
T/O Rate:0.91%
Dividend:2.40
Dividend Rate:1.09%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.84
PE(LYR):21.20

Loading ...

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 04

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 01

Sell Winning Stocks at 0% Federal Tax, Reinvest Same Day: Wash Sale Rules Don't Apply

Deep News
·
Jul 31

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 30

NYSE Order Imbalance 75737.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

ResMed Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

BofA Adjusts Price Target on ResMed to $320 From $310

MT Newswires Live
·
Jul 24

ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says

MT Newswires Live
·
Jul 22

Resmed Bulls Think Acquisition Timing Looks Awkward

Dow Jones
·
Jul 21

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

MT Newswires Live
·
Jul 17

ResMed downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jul 16

ResMed price target lowered to $220 from $235 at Mizuho

TIPRANKS
·
Jul 15

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 15

Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating

MT Newswires Live
·
Jul 14

Cleveland Medical Devices: Won Favorable Ptab Outcomes in 5 of 6 Resmed Ipr Challenges

THOMSON REUTERS
·
Jul 14

Cleveland Medical Devices: in Four of Five Proceedings, Ptab Determined That Co Had not Established That Challenged Claims were Unpatentable

THOMSON REUTERS
·
Jul 14

Movement Alert|ResMed Falls 5.61% in Regular Trading, Citi Downgrades Rating to Neutral Triggering Sell-Off

Market Focus
·
Jul 13

Movement Alert|ResMed Falls 5.19% in Pre-Market Trading, Citi Downgrades Rating to Neutral

Market Focus
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 13

Resmed Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jul 13